Factors associated with the use of psychoactive drugs in institutionalized elderly;Fatores associados ao uso de psicofármacos em idosos asilados

Revista de Psiquiatria do Rio Grande do Sul

Volumn 32, Issue 2, 2010, Pages 38-43

  Lucchetti, Giancarlo ^a   Granero, Alessandra Lamas ^b,c   Pires, Sueli Luciano ^a,c,d   Gorzoni, Milton Luiz ^a,c   Tamai, Sérgio ^b,e  

^a IRMANDADE DA SANTA CASA DE MISERICÓRDIA DE SÃO PAULO   (Brazil)

^b FACULDADE DE CIÊNCIAS MÉDICAS DA SANTA CASA DE SÃO PAULO   (Brazil)

^c Centro Interdisciplinar de Assistência e Pesquisa em Envelhecimento CIAPE   (Brazil)

^d Hospital Geriátrico e de Convalescentes Dom Pedro II   (Brazil)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antipsychotics; Elderly; Nursing homes; Psychoactive drugs

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CLONAZEPAM; DIAZEPAM; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LORAZEPAM; NEUROLEPTIC AGENT; NORTRIPTYLINE; PAROXETINE; PSYCHOTROPIC AGENT; RISPERIDONE; SERTRALINE;

AGED; ARTICLE; BEHAVIOR DISORDER; DEMENTIA; DRUG USE; ELDERLY CARE; FEMALE; HEAD INJURY; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NURSING HOME; POLYPHARMACY; STROKE;

EID: 77957225926     PISSN: 01018108     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0101-81082010000200003     Document Type: Article

References (34)

1. National Disease and Therapeutic Index - IMS Health; December 2000 [Internet] [accessed 2009 Jun 18]. Available from: https://web01.imshealth.com/ ndti/ndtilogin.aspx
2. Stella F, Caetano D, Pacheco JL, Sé EVG, Lacerda ALT. Factors influencing psychotropic prescription by non-psychiatrist physicians in a nursing home for the elderly in Brazil. Sao Paulo Med J. 2006;124(5):253-6.
3. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294:1934-43.
4. Ballard C, Hanney ML, Theodoulou M, Douglas S, McShane R, Kossakowski K, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol. 2009;8(2):151-7.
5. Camarano AA. Brazilian population ageing: differences in well-being by rural and urban areas [Internet]. Geneva: United Nations; 2002 [accessed 2009 May 24; 33 screens]. Available from: http://www.ipea.gov.br
6. Camarano AA. Instituições de longa permanência e outras modalidades de arranjos domiciliares para idosos. In: Néri AL, org. Idosos no Brasil: vivência, desafios e expectativas na terceira idade. São Paulo: Fundação Perseu Abramo, 2007. p. 1-288.
7. Araújo MOPH, Ceolim MF. Avaliação do grau de independência de idosos residentes em instituições de longa permanência. Rev Esc Enferm USP. 2007;41(3):378-85.
8. Orlandi P, Noto AR. Uso indevido de benzodiazepínicos: um estudo com informantes-chave no município de São Paulo. Rev Latinoam Enferm. 2005;13(especial):896-902.
9. Chaimowicz F, Greco DB. Dinâmica da institucionalizaçã o de idosos em Belo Horizonte, Brasil. Rev Saude Publica. 1999;33(5):454-60.
10. Mamun K, Goh-Tan CYE, Ng LL. Prescribing psychoactive medications in nursing homes: current practice in Singapore. Singapore Med J. 2003;12:625-9.
11. van Dijk KN, de Vries CS, van den Berg PB, Brouwers JRBJ, de Jong-van den Berg LTW. Drug utilisation in Dutch nursing homes. Eur J Clin Pharmacol. 2000;55(10):765-71.
12. Taylor LF. Psychotropic drug use in a nursing home: a 6-year retrospective. J Appl Gerontol. 2003;22(4):474-89.
13. Nygaard HA, Naik M. Use of psychotropic drugs in homes for the aged in Bergen, Norway: a comparative study. Norwegian J Epidemiol. 1998;8(2):133-8.
14. Snowdon J. A follow-up survey of psychotropic drug use in Sydney nursing homes. Med J Aust. 1999;170:299-301.
15. Lakey SL, Gray SL, Sales AE, Sullivan J, Hedrick SC. Psychotropic use in community residential care facilities: a prospective cohort study. Am J Geriatr Pharmacother. 2006;4(3):227-35. (Pubitemid 44739619)
16. Briesacher BA, Limcangco R, Simoni-Wastila L, Doshi JA, Levens SR, Shea DG, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med. 2005;165:1280-5.
17. Rochon PA, Stukel TA, Bronskill SE, Gomes T, Sykora K, Wodchis WP, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med. 2007;167(7):676-83. (Pubitemid 46598460)
18. Liperoti R, Mor V, Lapane KL, Pedone C, Gambassi G, Bernabei R. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry. 2003;64(9):1106-12.
19. Shorr RI, Fought RL, Ray WA. Changes in antipsychotic drug use in nursing homes during implementation of the OBRA-87 regulations. JAMA. 1994;5:358-62.
20. Pitkala KH, Laurila JV, Strandberg TE, Tilvis RS. Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards. Int Psychogeriatr. 2004;16:61-74.
21. Snowdon J, Day S, Baker W. Why and how antipsychotic drugs are used in 40 Sydney nursing homes. Int J Geriatr Psychiatry. 2005;20(12):1146-52.
22. Siqueira GR, Vasconcelos DT, Duarte GC, Arruda IC, Costa JAS, Cardoso RO. Análise da sintomatologia depressiva nos moradores do Abrigo Cristo Redentor através da aplicação da Escala de Depressão Geriátrica (EDG). Cienc Saude Coletiva. 2009;14(1):253-9.
23. Oliveira CAA, Lima SA. Idoso em movimento: proposta para melhor qualidade de vida na velhice [monografia]. Recife: Universidade Federal de Pernambuco; 2001. 68 f.
24. Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-24.
25. Schnelle JF, Ouslander JG, Simmons SF, Alessi CA, Gravel MD. The nighttime environment, incontinence care, and sleep disruption in nursing homes. J Am Geriatr Soc. 1993;41(9):910-4.
26. Kim H, Whall AL. Factors associated with psychotropic drug usage among nursing home residents with dementia. Nurs Res. 2006;55(4):252-8.
27. Loyola Filho AI, Uchoa E, Firmo JOA, Lima-Costa MF. Influência da renda na associação entre disfunção cognitiva e polifarmácia: Projeto Bambuí. Rev Saude Publica. 2008;42(1):89-99.
28. Wortmann AC, Grüdtner MC, Fialho AF, Jardim Neto JC, Schaefer LG, Sehn F, et al. O consumo de benzodiazepínicos em Porto Alegre. Rev Ass Med Bras. 1994;40(4):265-70.
29. Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol. 1999;19(2):132-40.
30. Linjakumpu T, Hartikainen S, Klaukka T, Koponen H, Kivela SL, Isoaho R. Psychotropics among the home-dwelling elderly - increasing trends. Int J Geriatr Psychiatry. 2002;17(9):874-83.
31. Holmquist IB, Svensson B, Hoglund P. Psychotropic drugs in nursing- and oldage homes: relationships between needs of care and mental health status. Eur J Clin Pharmacol. 2003;59(8-9):669-76.
32. Hohmann AA. Gender bias in psychotropic drug prescribing in primary care. Med Care. 1989;27(5):478-90.
33. Ott BR, Lapane KL, Gambassi G. Gender differences in the treatment of behavior problems in Alzheimer's disease. Neurology. 2000;54:427-32.
34. Lindesay J, Matthews R, Jagger C. Factors associated with antipsychotic drug use in residential care: changes between 1990 and 1997. Int J Geriatr Psychiatry. 2003;18(6):511-9.